# INTERVENCION Trial

Study · id `cardio:ct-nct02373163` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02373163](<https://clinicaltrials.gov/study/NCT02373163>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02373163

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 166 participants.

## Technical summary

Registry record NCT02373163. Randomized; single masking; primary purpose treatment. Start 2014-09-01 (actual); primary completion 2016-03-01 (actual). Results posted on 2025-07-29.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 166 participants (enrolled count; ClinicalTrials.gov record NCT02373163, source copy `cardio:ctgov-nct02373163-2025-07-29`, retrieved 2026-10-26)
- Started: 2014-09-01 (actual) (ClinicalTrials.gov record NCT02373163, source copy `cardio:ctgov-nct02373163-2025-07-29`, retrieved 2026-10-26)
- Primary completion: 2016-03-01 (actual) (ClinicalTrials.gov record NCT02373163, source copy `cardio:ctgov-nct02373163-2025-07-29`, retrieved 2026-10-26)
- Completion: 2016-06-01 (actual) (ClinicalTrials.gov record NCT02373163, source copy `cardio:ctgov-nct02373163-2025-07-29`, retrieved 2026-10-26)
- Results first posted: 2025-07-29 (ClinicalTrials.gov record NCT02373163, source copy `cardio:ctgov-nct02373163-2025-07-29`, retrieved 2026-10-26)
- Countries: Peru (ClinicalTrials.gov record NCT02373163, source copy `cardio:ctgov-nct02373163-2025-07-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02373163-2025-07-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: INTERVENCION Trial
- Acronym: INTERVENCION
- Condition: Blood Pressure, High
- Intervention (Drug): Hydrochlorothiazide
- Intervention (Drug): Amlodipine
- Intervention (Drug): Telmisartan
- Lead sponsor: Prevencion
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Hydrochlorothiazide (`cardio:hydrochlorothiazide`)
- Registry intervention name matches this record: Amlodipine (`cardio:amlodipine`)
- Registry intervention name matches this record: Telmisartan (`cardio:telmisartan`)

## Provenance

Content hash: 774b9480a1bf1a38a962faa0bd3e786158583305d47adf1f01829c9610b21636
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
